45 results
Page 2 of 3
8-K
EX-99.1
th78gqq
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
424B3
w5hn5lge91 ymtmdd
14 Jan 22
Prospectus supplement
5:18pm
424B5
hmdm8a q9vrdny7zc4rx
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
fdku9r8jl09
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
tchq9cj8r3pi1
22 Nov 21
Definitive proxy
4:37pm
424B5
ju0x sdm4
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
w1f60z
14 May 21
Quarterly report
4:31pm
10-K
EX-10.2
gcwz3mu5
31 Mar 21
Annual report
4:30pm
10-K
uf5u 1dchin
31 Mar 21
Annual report
4:30pm
S-3
1l9 nhezcrus8nrp3sy8
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.2
4wu1u pmrq1yjq1
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.1
vsy63x56ili22vse4zp
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-99.1
whms4au 7cy
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
jxhw6pad9kdri31bhpm
2 Nov 20
Prospectus supplement
12:00am